Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Net Debt · Q4 FY2024 · quarter ended Mar 2025
Net debt turns positive
Q4 FY2024 net debt was $343.87K, compared with -$1.14M a year earlier.
Context
- Net debt amounted to 6.4% of total assets at the end of Q4 FY2024, down 17.0 pp from a year earlier.
- Net debt increased in 1 of the last 2 fiscal years.
- FY2024 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether net debt keeps rising in the next quarterly balance sheet after a +130.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Debt history
USD · from the balance sheet
- Latest · FY2024
- 343.87K USD
- Year-over-year change
- +130.1%
| Period | Period end | Net Debt | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 343.87K | +130.1% |
| FY2023 | 2024-03-31 | (1.14M) | -854.5% |
| FY2022 | 2023-03-31 | (119.68K) | — |
Net Debt vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 net debt of $343.87K is the 3rd highest of the 10 companies compared; the peer median is -$40.41M.
- Its year-over-year change of +130.1% is the 2nd highest of 10, against a peer median of -33.8%.
- Net debt amounts to 6.4% of total assets for MCTA, versus a peer median of 23.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $174.44M | +36887.6% | +871.7% | 28.1% | |
| Mar 2026 | $74.58M | +19.2% | -9.4% | 44.3% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $343.87K | +130.1% | — | 6.4% |
| Mar 2026 | -$6.75M | +57.7% | — | 2.2% | |
| Feb 2026 | -$25.22M | -147.3% | — | 17.2% | |
| Mar 2026 | -$40.41M | -243.6% | — | 32.4% | |
| Mar 2026 | -$59.82M | -49.6% | — | 22.0% | |
| Mar 2026 | -$103.54M | -33.8% | — | 23.0% | |
| Mar 2026 | -$106.59M | -10.3% | — | 7.1% | |
| Mar 2026 | -$149.77M | -117.7% | — | 57.0% | |
| Peer median (excluding MCTA) | -$40.41M | -33.8% | +431.2% | 23.0% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.